A Look At Advanced Micro Devices (AMD)’s Valuation After Record Q1 Results And Major AI Partnerships

Advanced Micro Devices (AMD) stock is back in focus after record Q1 2026 results, stronger Q2 revenue guidance, and new AI focused partnerships with Meta, Samsung, TCS, OpenAI, and other large customers.

See our latest analysis for Advanced Micro Devices.

Even after a strong run, the share price is still moving around short term, with a 1 day share price return of 3.07% in the red following a 7 day share price return of 15.22%. The 30 day share price return of 84.38% and 1 year total shareholder return above 300% point to powerful momentum that recent Q1 results, higher Q2 guidance and fresh AI partnerships have brought back into focus.

If AMD’s surge has you looking at the wider AI chip space, this is a good moment to see what else is moving and uncover 39 AI infrastructure stocks

With AMD shares up more than 300% over the past year and trading just below many analysts' targets, the key question is simple: is there still mispricing here, or is the market already baking in years of AI growth?

Advertisement

Most Popular Narrative: 9.2% Undervalued

AMD’s most followed narrative pegs fair value at $450 per share, above the last close at $408.46, which puts current pricing in the spotlight.

Advanced Micro Devices (AMD) released its Q1 2026 financial results on May 5, 2026, delivering a "blowout" performance that has fundamentally shifted investor sentiment. Driven by a massive structural pivot toward AI infrastructure, the company exceeded analyst estimates across every primary metric. AMD is no longer just "the other chip company." It has successfully rewritten its thesis as a primary architect of the AI era. While the valuation is stretched, the fundamental growth in data centre revenue and the raised long-term TAM suggest that the premium may be justified if execution remains flawless.

Read the complete narrative.

Want to see what sits behind that $450 figure and 9.2% gap? The narrative leans heavily on acceleration in earnings, high AI infrastructure demand, and richer long term margins.

According to oscargarcia, the narrative treats AMD as a full scale AI infrastructure platform, not just a chip supplier, with data center, client, gaming, and embedded all feeding into that fair value. It also assumes that current earnings growth and margin trends can support that valuation at a discount rate of 9.54%, even with the share price already up sharply over the past year.

Result: Fair Value of $450 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this hinges on AMD keeping pace with Nvidia in high end AI GPUs, as well as managing export controls that could pressure margins and limit AI chip sales.

Find out about the key risks to this Advanced Micro Devices narrative.

Another View: Earnings Multiple Sends a Louder Warning

That 9.2% “undervalued” fair value at $450 sits awkwardly next to where the market is actually pricing AMD today. The stock is on a P/E of about 135x, compared with a fair ratio of 75.8x, the US Semiconductor industry at 59.8x, and peers at 38.2x.

In plain terms, the current price asks you to accept a much richer earnings multiple than both the sector and peer group, and even the fair ratio that the market could move toward over time. If sentiment cools or forecasts reset, how much compression in that gap are you comfortable with?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:AMD P/E Ratio as at May 2026
NasdaqGS:AMD P/E Ratio as at May 2026

Next Steps

With sentiment clearly split between opportunity and caution, this is a good moment to move quickly, review the full picture, and weigh both the 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If AMD feels fully priced, do not stop there. Use this moment to refresh your watchlist with other opportunities that could fit your style and risk comfort.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:AMD

Advanced Micro Devices

Operates as a semiconductor company internationally.

Exceptional growth potential with solid track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1157.5% undervalued
48 users have followed this narrative
2 users have commented on this narrative
8 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7721.4% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9218.9% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$19013.7% undervalued
24 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative

Updated Narratives

WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.8% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BL
Blagget
TERA logo
Blagget on Terra Balcanica Resources ·

The C$4M Explorer Positioned to Become Europe's First Antimony Mine

Fair Value:CA$0.487.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CHTR logo
david_6nroa on Charter Communications ·

Charter is undervalued - Here's why.

Fair Value:US$87.0741.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.919.1% undervalued
81 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28026.1% undervalued
187 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.6% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0